Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioartificial liver support.

T Hui1, J Rozga, A A Demetriou

  • 1Department of Surgery, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA.

Journal of Hepato-Biliary-Pancreatic Surgery
|April 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and roles of GRAS gene family in plant growth, signal transduction, biotic and abiotic stress resistance and symbiosis formation-a review.

Plant biology (Stuttgart, Germany)·2021
Same author

The 1997 Mars Pathfinder Spacecraft Landing Site: Spillover Deposits from an Early Mars Inland Sea.

Scientific reports·2019
Same author

EZH2 Impairs Human Dental Pulp Cell Mineralization via the Wnt/β-Catenin Pathway.

Journal of dental research·2018
Same author

Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia.

Leukemia·2017
Same author

Epigenetic regulation in dental pulp inflammation.

Oral diseases·2016
Same author

Development and testing of a bioartificial liver.

Surgical technology international·2015
Same journal

In situ surgical procedures for locally advanced pancreatic cancer: partial abdominal evisceration and intestinal autotransplantation.

Journal of hepato-biliary-pancreatic surgery·2009
Same journal

Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?

Journal of hepato-biliary-pancreatic surgery·2009
Same journal

Pancreatectomy with reconstruction of the right and left hepatic arteries for locally advanced pancreatic cancer.

Journal of hepato-biliary-pancreatic surgery·2009
Same journal

Combined TIPS with portal-azygous disconnection improved the long term clinical outcome in portal hypertension patients.

Journal of hepato-biliary-pancreatic surgery·2009
Same journal

Assessing the appropriate use of laparoscopic surgery for hepatobiliary diseases.

Journal of hepato-biliary-pancreatic surgery·2009
Same journal

Laparoscopic hand-assisted right hemihepatectomy by ultrasound-directed intrahepatic approach.

Journal of hepato-biliary-pancreatic surgery·2009
See all related articles

Developing extracorporeal liver support is crucial for fulminant hepatic failure (FHF) patients awaiting transplants. A bioartificial liver support system using porcine hepatocytes shows promise in maintaining patients until organ availability.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Transplantation Medicine

Background:

  • Orthotopic liver transplantation is the definitive treatment for fulminant hepatic failure (FHF).
  • Organ shortages lead to high mortality rates in FHF patients awaiting transplants.
  • Rapid deterioration, including cerebral edema, necessitates urgent liver support.

Purpose of the Study:

  • To review the history of extracorporeal liver support (ELS) for acute liver failure.
  • To discuss the authors' experience with a specific bioartificial liver support (BALS) system.
  • To evaluate the potential of ELS in bridging FHF patients to transplantation.

Main Methods:

  • Review of historical ELS approaches for acute liver failure.
  • Description of a hollow fiber BALS system utilizing porcine hepatocytes.

Related Experiment Videos

  • Clinical application of the BALS system in FHF patients.

    • Main Results:

    • Previous ELS systems have not achieved widespread clinical use.
    • The hollow fiber BALS system with porcine hepatocytes was applied to FHF patients.
    • Further data on the efficacy and outcomes of this specific BALS system are discussed.

    Conclusions:

    • ELS is essential for maintaining FHF patients until liver transplantation.
    • Bioartificial liver support systems represent a promising therapeutic strategy.
    • The use of porcine hepatocytes in BALS warrants further investigation for acute liver failure management.